Adding biologic agents to chemotherapy improves survivability in cancer patients—for both Black and white patients
A trio of researchers working at the Albert Einstein College of Medicine has found that giving biologic agents to metastatic colorectal cancer patients improved survivability for black and white patients nearly equally. In ...